Results: 3

1.
Figure 1

Figure 1. From: Ribonucleotide Reductase Expression in Cervix Cancer: a Radiation Therapy Oncology Group Translational Science Analysis.

STROBE diagram for progress through stages of analysis. STROBE: Strengthening the Reporting of Observational Studies in Epidemiology.

Charles A. Kunos, et al. Int J Gynecol Cancer. ;23(4):615-621.
2.
Figure 3

Figure 3. From: Ribonucleotide Reductase Expression in Cervix Cancer: a Radiation Therapy Oncology Group Translational Science Analysis.

RNR M1, M2, and M2b immunoreactivity in cancer tissues and incidence of metastases to pelvic lymph nodes (A) and to para-aortic lymph nodes (B) at diagnosis.

Charles A. Kunos, et al. Int J Gynecol Cancer. ;23(4):615-621.
3.
Figure 2

Figure 2. From: Ribonucleotide Reductase Expression in Cervix Cancer: a Radiation Therapy Oncology Group Translational Science Analysis.

Ribonucleotide reductase M1, M2, and M2b immunoreactivity in uterine cervix cancers. Depicted are examples of brown color staining intensity for M1 (A 1+, B 3+); M2 (C 1+, D 3+); and M2b (E 1+, F 3+). Magnification is indicated.

Charles A. Kunos, et al. Int J Gynecol Cancer. ;23(4):615-621.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk